Talis Biomedical Corporation (TLIS) Financials
TLIS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 82.5 million | 25.8 million |
| 2023-12-31 | 98.3 million | 29.2 million |
| 2023-09-30 | 107.2 million | 25.7 million |
| 2023-06-30 | 123.1 million | 26.9 million |
TLIS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -6.4 million | 601000 |
| 2023-12-31 | -11.3 million | 1.0 million |
| 2023-09-30 | -11.2 million | 1.1 million |
| 2023-06-30 | -14.8 million | 1.1 million |
TLIS Net Income
No data available :(
TLIS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 70.3 million | - | 19.2 million |
| 2023-12-31 | 76.7 million | - | 19.7 million |
| 2023-09-30 | 88.0 million | - | 20.1 million |
| 2023-06-30 | 98.2 million | - | 20.4 million |
TLIS Shares Outstanding
TLIS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 2.5 million | 11.7 million | - |
| 2023-12-31 | 93000 | 8.0 million | 6.6 million | - |
| 2023-09-30 | 70000 | 8.3 million | 8.8 million | - |
| 2023-06-30 | 485000 | 10.6 million | 6.4 million | - |
TLIS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 73000 | 268000 |
| 2023-12-31 | 151000 | 622000 |
| 2023-09-30 | 76000 | 6000 |
| 2023-06-30 | 48000 | 7000 |
TLIS
Price: $9.20
52 week price:
Earnings Per Share: -34.12 USD
P/E Ratio: -0.20
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 73600
Market Capitalization: 16.1 million